CA2215383A1 - Recepteur humain du facteur de necrose tumorale - Google Patents

Recepteur humain du facteur de necrose tumorale Download PDF

Info

Publication number
CA2215383A1
CA2215383A1 CA002215383A CA2215383A CA2215383A1 CA 2215383 A1 CA2215383 A1 CA 2215383A1 CA 002215383 A CA002215383 A CA 002215383A CA 2215383 A CA2215383 A CA 2215383A CA 2215383 A1 CA2215383 A1 CA 2215383A1
Authority
CA
Canada
Prior art keywords
polypeptide
receptor
polynucleotide
tnf
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002215383A
Other languages
English (en)
Inventor
Robert D. Fleischmann
John M. Greene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002215383A priority Critical patent/CA2215383A1/fr
Publication of CA2215383A1 publication Critical patent/CA2215383A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

On décrit un récepteur humain du facteur de nécrose tumorale (TNF), l'ADN (ARN) codant ce récepteur, ainsi qu'un procédé de production d'un tel récepteur à l'aide de techniques de recombinaison. On décrit également: des méthodes d'utilisation d'un tel récepteur pour cribler des antagonistes et des agonistes de ce récepteur, ainsi que des ligands de celui-ci; des méthodes d'utilisation de tels agonistes pour inhiber la croissance des tumeurs, pour stimuler la différentiation cellulaire, pour induire la réponse immune et la réponse antivirale, pour réguler la croissance et conférer une résistance à certaines infections; l'utilisation de ces antagonistes en tant qu'agents thérapeutiques pour traiter des maladies auto-immunes, l'inflammation, le choc septique, pour inhiber les réactions greffon/hôte, et pour prévenir l'apoptose. On décrit encore des méthodes de diagnostic permettant de détecter des mutations dans la séquence d'acide nucléique codant ce récepteur, ainsi que des niveaux modifiés du récepteur soluble dans un échantillon dérivé d'un hôte.
CA002215383A 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale Abandoned CA2215383A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002215383A CA2215383A1 (fr) 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002215383A CA2215383A1 (fr) 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale

Publications (1)

Publication Number Publication Date
CA2215383A1 true CA2215383A1 (fr) 1996-09-19

Family

ID=4161465

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002215383A Abandoned CA2215383A1 (fr) 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale

Country Status (1)

Country Link
CA (1) CA2215383A1 (fr)

Similar Documents

Publication Publication Date Title
EP2017337A1 (fr) Récepteur du facteur onconécrosant humain
AU708972B2 (en) Tumor necrosis factor-gamma
US6511826B2 (en) Polynucleotides encoding human G-protein chemokine receptor (CCR5) HDGNR10
US6743594B1 (en) Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US7094564B1 (en) Human tumor necrosis factor receptor
US20020127651A1 (en) Human 4-1BB receptor splicing variant
AU723891B2 (en) Human chemokine beta-11 and human chemokine alpha-1
CA2211003A1 (fr) Recepteur du facteur de necrose des tumeurs humain
AU713267B2 (en) Human chemokine beta-13
US20040151719A1 (en) Human G-protein chemokine receptor (CCR5) HDGNR10
US20030166097A1 (en) Human tumor necrosis factor receptor
WO1996039520A1 (fr) Chemokine beta-12 humaine
EP1146055A2 (fr) Chemokine recepteur HDGNR10 aux proteines G humaines (recepteur CCR5)
US6537539B2 (en) Immune cell cytokine
EP0814661A1 (fr) Enzymes 7, 8 et 9 de conjugaison d'ubiquitine
US6130061A (en) Human stem cell antigen 2
CA2215383A1 (fr) Recepteur humain du facteur de necrose tumorale
AU753730B2 (en) Human chemokine beta-13
US20040038347A1 (en) Apoptosis inducing molecule I
AU716415B2 (en) Pineal gland specific gene-1
AU750982B2 (en) Human chemokine beta-11 and human chemokine alpha-1
AU753309B2 (en) Pineal gland specific gene-1
AU753088B2 (en) Human chemokine polypeptides
US5962268A (en) DNA encoding an immune cell cytokine
EP0819168A1 (fr) Recepteur humain du facteur de necrose tumorale

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued